MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
C2PU.SI stock logo

C2PU.SI

Parkway Life Real Estate Investment Trust

$4.02
-0.04
 (-0.99%)
[ms_data_label text=’Delayed data’]
Exchange:  SES
Market Cap:  2.624B
Shares Outstanding:  605.002M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Real Estate
Industry:  REIT – Healthcare Facilities
   
CEO:  Yean Chau Yong
Full Time Employees:  23
Address: 
80 Robinson Road, No. 02-00
Singapore
68898
SG
Website:  https://www.plifereit.com
Parkway Life Real Estate Investment Trust (“PLife REIT”) is one of Asia’s largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 54 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.02 billion3 as at 31 December 2020. It owns the largest portfolio of strategically-located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 50 assets of high quality nursing home and care facility properties in various prefectures of Japan. It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue147,467144,848164,994
Gross Profit124,593126,742134,606
EBITDA121,199113,883130,821
Operating Income121,585131,411130,821
Net Income100,46595,041152,790

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets2,334,1342,551,1472,652,978
Total Liabilities919,577981,195982,621
Total Stockholders Equity1,414,5571,569,9521,670,357
Total Debt828,471886,109887,542
Cash and Cash Equivalents28,49929,47147,771

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow108,68995,78699,489
Capital Expenditure-31,036-49,103-99,489
Free Cash Flow77,65346,6830
Net Income100,465101,736152,790
Net Change in Cash-11,51197218,300

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2029Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)245,324.256Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)280,422.779Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)262,587.169Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)200,789.229Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)229,516.129Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)214,918.313Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)35,812.473Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)42,616.909Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)39,159.180Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)7,704.226Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)8,806.469Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)8,246.355Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)0.060Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)0.070Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)0.050Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)2Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
22.91
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
38.94
?Enterprise Value
 (TTM)
: 
3.474B  ?EV/FCF
 (TTM)
: 
0
?Dividend Yield
 (TTM)
: 
0.04  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
0.04  ?ROIC
 (TTM)
: 
0.03
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.53
?P/B
 (TTM)
: 
1.58  ?Current Ratio
 (TTM)
: 
0.27

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
28.81Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate SI Intrinsic Value

Common questions about C2PU.SI valuation

Is Parkway Life Real Estate Investment Trust (C2PU.SI) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Parkway Life Real Estate Investment Trust (C2PU.SI) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is C2PU.SI a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether C2PU.SI trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is C2PU.SI’s P/E ratio?

You can see C2PU.SI’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for C2PU.SI?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is C2PU.SI a good long-term investment?

Whether C2PU.SI fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

C2PU.SI

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

[ms_data_label text="Daily snapshot"]

-0.99
MARKETSnap

Trading Metrics:

[ms_session_rows_unavailable]
Open: [ms_cell_or_dash table='trading_quote' column='open']   Previous Close: [ms_cell_or_dash table='trading_quote' column='previousClose']
Day Low: [ms_cell_or_dash table='trading_quote' column='dayLow']   Day High: [ms_cell_or_dash table='trading_quote' column='dayHigh']
Year Low: 3.92   Year High: 4.44
Price Avg 50: 4.02   Price Avg 200: 4.08
Volume: 1.554M   Average Volume: 1.144M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read